Rothmans Deal Presents Challenges for Philip Morris 2 comments
-
Font Size:
-
Print
- TweetThis
Philip Morris International Inc.’s friendly C$2-billion takeover of Canadian cigarette maker Rothmans Inc. (RMANF.PK) may not be material in financial terms given the U.S. tobacco giant’s more than $100-billion market capitalization, but it does increase its litigation exposure.
This factor, along with the extreme difficulty Philip Morris will have in bringing its brands to bear in Canada – it cannot use the Marlboro name, for example, since British American Tobacco plc owns the brand – has Citigroup’s Adam Spielman telling clients that he doesn’t like the deal.
He even had photos of du Maurier packs with a impotency-warning limp cigarette and stroke-worthy lung to demonstrate some of the challenges Canada presents.
While Philip Morris says its comfortable with the additional litigation risk it is taking on, the analyst said:
Pessimists could argue that the British Columbia and copycat cases are actually more threatening than anything in the U.S. Arguably the whole point of the spin-off that created Philip Morris was to get away from litigation risk.
Mr. Spielman said Canadian litigation is different from the rest of the world and provided in-depth analysis of the legal situation in British Columbia.
He also highlighted differences between the U.S. and Canadian markets, including the fact that 20% of consumption comes from non-name brands illegally smuggled from First Nation’s Reservations (more than 30% of consumption in Ontario and Quebec), the fact that Canadians smoke Virginia blend cigarettes and avoid American blend, “extremely tough” anti-tobacco regulation, and a consistent industry downtrend since 2003.
While Philip Morris probably would have preferred buying a cigarette company in an emerging market, this shows how few attractive targets are out there, the analyst said, noting that the deal will nonetheless be accretive.
Related Articles
|




























This article has 2 comments: